DNA polymerase iota (polɩ) is a member of low-fidelity Y-family of DNA polymerases. Our previous studies have demonstrated that the overexpression of polι is associated with the poorer prognosis in lung cancer patients. Here, we designed the small interfering RNA (siRNA) targeting polɩ gene (POLI) to investigate the effect of polɩ on the proliferation, apoptosis, and invasion of the lung cancer cell line A549 in order to reveal the role of polι in lung cancer progression. Our results showed that siRNA of POLI had no significant effect on the proliferation and apoptosis of the lung cancer cell line A549. However, siRNA of POLI could inhibit the migration and invasion of the lung cancer cell line A549 by upregulating the E-cadherin expression and downregulating the expressions of N-cadherin, MMP2, and MMP9. Together, our findings indicate that polι plays a positive role in lung cancer progression via promoting the migration and invasion of lung cancer cells. Therefore, polι might be a potential target for the clinical treatment of lung cancer in the future.
Introduction
Lung cancer is a malignant tumor with the highest incidence and mortality rates of malignant tumors worldwide. At present, therapies for lung cancer mostly include surgery, chemotherapy, and radiotherapy. However, the 5-year survival rate remains about 15% and still has not been notably increased during the last three decades [1] . Gene therapies that target and regulate gene expression have been developed rapidly in recent years.
The genome is continuously exposed to some damaging agents. Among the mechanisms employed to protect genetic integrity from detrimental effects of genotoxic compounds, translesion DNA synthesis (TLS) is an important process that replicates the damaged genomic DNA. At the same time, due to the effect of low-fidelity translesion polymerases, TLS is a potential mutagenic process. TLS capability has been shown to be associated with enhanced cancer risks in human [2, 3] . TLS polymerases mostly belong to the Y-family. DNA polymerase iota (polι) is a member of low-fidelity Y-family of DNA polymerases (polι, polκ, polη, and Rev1), participating in TLS for spontaneous and DNA damage-induced mutations during the course of translesional replication [4, 5] . The low-fidelity characteristics of these polymerases may contribute to malignant transformation as well as the accumulation of mutagenesis [6] [7] [8] . In the TLS process, polι has the lowest fidelity to bypass types of DNA lesions [9, 10] . Human polι has been shown to be related to the tumorigenesis and tumor progression. Polι was found to be upregulated in many primary tumor tissues such as breast, prostate, stomach, bladder, and esophageal cancers [11] [12] [13] [14] . Moreover, overexpression of polι is associated with the poorer prognosis in these cancer patients. Our previous studies also demonstrated that the overexpression of polι was associated with the poorer prognosis in lung cancer patients [15] .
RNA interference exhibits great potential as a new powerful therapeutic strategy based on its highly specific and efficient silencing of target genes [16] . Here, we established small interfering RNA (siRNA) of polι gene (POLI) to inhibit the expression of polι in lung cancer cells. We aimed to investigate the effect of siRNA of POLI (siRNA-POLI) on the proliferation, apoptosis, migration, and invasion of lung cancer cells, further study the mechanism of polι in tumorigenesis and development, and explore the potential value of POLI as a target for cancer therapy in lung cancer.
Materials and Methods

siRNA design and cell culture
Four target sequences of siRNA-POLI were designed ( Table 1) . A small RNA with random sequence (siRNA-NC) was used as negative control (NC). All siRNA and random sequences were synthesized by GenePharma (Shanghai, China) with 2′-deoxy modification. Human lung cancer cell line A549 was obtained from Institute of Biochemistry and Cell Biology (Shanghai, China) and cultured in RPMI 1640 medium (Gibco, Gaithersburg, USA) supplemented with 10% fetal bovine serum at 37°C with 5% CO 2 . A549 cells cultured in 6-well plates were transfected by lentivirus expression vectors (Invitrogen, Carlsbad, USA) with siRNA and random sequences at a concentration of 100 pmol per well using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. RNA isolation and protein isolation were performed after 48 h.
Quantitative real-time polymerase chain reaction
At 48 h after transfection, A549 cells were harvested and washed with PBS buffer. RNA was isolated according to the standard manufacturer's instruction with TRIzol reagent (Invitrogen). cDNA was synthesized by One-Step RNA PCR kit (TaKaRa, Dalian, China). Quantitative reverse transcription polymerase chain reaction (RT-PCR) was performed to evaluate the silence efficiency of the siRNA. The sequences of primers for the target genes were as follows: 5′-AT GGAAGGAAGCCTCATACAGT-3′ (F) and 5′-CATTGGGGTCAT CACATCATA-3′ (R) for POLI; 5′-CGGATTTGGTCGTATTGGG-3′ (F) and 5′-CTGGAAGATGGTGATGGGATT-3 (R) for β-actin.
Western blot analysis
Forty-eight hours after siRNA-POLI transfection, A549 cells were harvested by trypsinization and lysed with cell lysis buffer. The lysates were centrifuged at 14,000 g and the supernatants were collected. Equal amount of cell lysates were subject to 10% SDS-PAGE and then transferred onto nitrocellulose membranes. Membranes were blocked with 4% skim milk in Tris-buffered saline, and then incubated with primary antibodies against polι, E-cadherin, Ncadherin, vimentin, β-catenin, MMP2, MMP9, and β-actin (Cell Signaling Technology, Boston, USA) overnight at 4°C. After extensive wash, membranes were incubated with peroxidase-conjugated secondary antibody (Cell Signaling Technology). Detection was performed using ECL kit (Sigma, St Louis, USA). Band density was quantified using Alpha Imager (Alpha Innotech Corporation, San Leandro, USA).
Cell proliferation assay A549 cells (5 × 10 3 cells/well) were seeded into 96-well plates and cultured for 24, 48, and 72 h. Cell proliferation was assessed using Cell Counting Kit-8 (CCK8; KeyGEN, Nanjing, China). All experiments were conducted in triplicate. Absorbance values of all wells were determined at 450 nm with a microplate reader (Sigma).
Flow cytometry analysis
Forty-eight hours after siRNA-POLI transfection, A549 cells were collected and fixed with 70% ice-cold ethanol for cell cycle analysis using Cell Cycle Detection Kit (KeyGEN) including RNase A and propidium iodide (PI). A549 cells with the transfection of siRNA-POLI were collected by digesting with 0.25% trypsin without ethylene diamine tetraacetic acid for apoptosis analysis using the annexin V-FITC cell apoptosis detection kit (KeyGEN) according to the manufacturer's instructions. Cell apoptosis was detected by flow cytometry. Data were analyzed using the software WinMDI2.9.
Cell migration assay
For cell migration assay, wound healing experiment was performed. Briefly, cells were subcultured in six-well plates at a density of 1 × 10 5 cells/well. Upon about 80% confluence, the cell monolayer was gently scraped with a yellow pipette tip to generate a linear wound and washed twice with serum-free medium to remove cell debris. Photos were subsequently taken at 0, 6, 24, 30, and 48 h. The closure of the wounds was enumerated by the distance of cells moved into the wounded area.
Cell invasion experiment
For cell invasion experiments, transwell chambers (6.5 mm diameter inserts with 8.0-μm pore polycarbonate membrane) of 24-well plates (Costar, Corning, USA) were used. Cells were collected and resuspended in the FBS-free RPMI 1640 medium at a concentration of 5 × 10 5 cells/ml by cell counting for three times. Then, cell suspensions were put into the upper compartment of the transwell chambers (200 μl/well), and RPMI 1640 medium containing 10% FBS was put into the lower compartment (600 μl/well). After 24 h of incubation at 37°C, cells that did not penetrate the polycarbonate membrane were wiped off with cotton swabs. The membrane was removed and fixed with methanol and stained with eosine solution. Five vision fields were randomly selected under a ZX81 microscope (Olympus, Tokyo, Japan) and the number of cells that penetrated the membrane was counted.
Statistical analysis
All data are expressed as the mean ± SD from at least three independent experiments by SPSS software. Statistical differences between different test conditions were determined using Student's t-test. The significance level was set at P < 0.05. 
Results
siRNA-POLI leads to a significant silencing efficiency
qRT-PCR assay showed that all siRNA-POLI significantly downregulated the expression of POLI in A549 cells. Among them, the silencing efficiencies of siRNA-POLI-2 and siRNA-POLI-3 were the highest (Fig. 1A) . Western blot analysis showed that the polι expression was downregulated significantly in A549 cells 48 h after transfection with siRNA-POLI-2 and siRNA-POLI-3 (Fig. 1B) .
siRNA-POLI has no significant effect on the proliferation and apoptosis of lung cancer cell line A549
Cell proliferation assay showed that the cell proliferation in siRNA-POLI-2-and siRNA-POLI-3-tranfected cells had no significant differences when compared with that in cells transfected with NC siRNA (P > 0.05; Fig. 2A ). Cell cycle analysis showed that the proportion of G1, G2, and S phase of the siRNA-transfected A549 cells had no significant difference in comparison with that of the NC-transfected cells (Fig. 2B) . These results demonstrated that siRNA-POLI had no influence on the proliferation of lung cancer cells. The findings of apoptosis analysis by flow cytometry showed that the apoptotic ratios of A549 cells transfected with siRNA-POLI-2 and siRNA-POLI-3 (6.08% ± 0.16% and 6.02% ± 0.23%) had no significant difference compared to that of cells transfected with NC siRNA (5.82% ± 0.34%) (P > 0.05; Fig. 2C ). These data indicated that siRNA-POLI had no effect on the apoptosis of lung cancer cells.
siRNA-POLI inhibits the migration and invasion of lung cancer cell line A549
The results of wound healing experiment showed that the migration of A549 cells transfected with siRNA-POLI-2 and siRNA-POLI-3 was obviously inhibited compared with the controls (Fig. 3A) .
The invasion experiment showed that the number of cells penetrating the membrane after the transfection with siRNA-POLI-2 and siRNA-POLI-3 was significantly decreased compared to that of cells transfected with NC siRNA (Fig. 3B) . These data indicated that siRNA-POLI could reduce the capacity of migration and invasion of lung cancer cells. MMP2, and MMP9 in A549 cells as compared to transfection with NC siRNA, while the level of vimentin expression had no significant difference between the siRNA-POLI group and the control group (Fig. 4) . These data indicated that siRNA-POLI could inhibit the invasion by promoting the upregulation of E-cadherin expression and the downregulation of N-cadherin, MMP2 and MMP9 expression in A549 cells.
Discussion
The poor prognosis of lung cancer is associated with tumor metastasis [17] . Cancer cell metastasis is a complex process including uncontrolled proliferation, angiogenesis, adhesion, migration, and invasion [18] . In this study, the siRNA of DNA polymerase iota gene (siRNA-POLI) was established successfully and could significantly inhibit the expression of POLI in lung cancer cells A549. Our results showed that siRNA-POLI had no significant effect on the proliferation and apoptosis of lung cancer cells. However, it could inhibit the migration and invasion of lung cancer cells. Our previous studies demonstrated that the overexpression of polι is associated with the poorer prognosis in lung cancer patients [15] . Together, these findings suggested that polι could promote the metastasis in lung cancer patient via promoting the migration and invasion of lung cancer cells. Furthermore, the mechanistic study identified that siRNA-POLI could upregulate the expression of E-cadherin and downregulate the expressions of N-cadherin, MMP2 and MMP9 in A549 cells. Thus, we demonstrated that the promoting effect of polι on the migration and invasion of lung cancer cells was due to reduced expression of E-cadherin and increased expressions of N-cadherin, MMP2, and MMP9. E-Cadherin and N-cadherin are the members of Cadherin families, participating in the cell adhesion and movement. Many aggressive tumors are characterized by reduced E-cadherin expression and increased N-cadherin expression, contributing to tumor cellular adhesion, motility, and invasive properties [19, 20] . MMP2 and MMP9, the major members of matrix metalloproteinase (MMP) family, are reported to be associated with tumor invasion and lymph node metastasis in many malignancies [21] [22] [23] .
In conclusion, siRNA of POLI inhibits the migration and invasion of lung cancer cells by the upregulation of E-cadherin expression and the downregulation of N-cadherin, MMP2, and MMP9 expression. These findings reveal a positive role for polι in lung cancer progression. Therefore, polι might be a potential target for the clinical treatment of lung cancer in the future.
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